These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8888211)
21. Tacrine and lecithin in Alzheimer's disease. Serum tacrine concentrations too low. Roberts C; Mäkelä P; Ford J; Truman C BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019289 [No Abstract] [Full Text] [Related]
22. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. Davis KL; Thal LJ; Gamzu ER; Davis CS; Woolson RF; Gracon SI; Drachman DA; Schneider LS; Whitehouse PJ; Hoover TM N Engl J Med; 1992 Oct; 327(18):1253-9. PubMed ID: 1406817 [TBL] [Abstract][Full Text] [Related]
37. [Tacrine: progress in treatment of Alzheimer's disease?]. Kurz A; Marquard R; Mösch D Z Gerontol Geriatr; 1995; 28(3):163-8. PubMed ID: 7664190 [TBL] [Abstract][Full Text] [Related]
38. Tacrine for treating Alzheimer's disease. Small GW JAMA; 1992 Nov; 268(18):2564-5. PubMed ID: 1404825 [No Abstract] [Full Text] [Related]
39. Tacrine for Alzheimer's disease. Costs and benefits. Knopman D Pharmacoeconomics; 1995 Apr; 7(4):275-9. PubMed ID: 10172459 [No Abstract] [Full Text] [Related]
40. Tacrine. Alzheimer's disease and the cholinergic theory. A critical review and results of a new therapy. Boller F; Orgogozo JM Neurologia; 1995 May; 10(5):194-9. PubMed ID: 7619536 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]